These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3932044)

  • 21. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.
    Lam SK; Lau WY; Choi TK; Lai CL; Lok AS; Hui WM; Ng MM; Choi SK
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):68S-74S. PubMed ID: 3080292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study.
    Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experiences with misoprostol].
    Herting RL; Nissen CH
    Fortschr Med; 1986 Nov; 104(44):865-8. PubMed ID: 3100408
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
    Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A
    Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current directions in the treatment of gastric and duodenal ulcers].
    Fellus R
    Dakar Med; 1988; 33(1-4):42-4. PubMed ID: 2908566
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue.
    Nicholson PA
    S Afr Med J; 1988 Jul; 74 Suppl():56-8. PubMed ID: 3133797
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
    Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
    Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study.
    Sontag SJ; Mazure PA; Pontes JF; Beker SG; Dajani EZ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):159S-163S. PubMed ID: 3932049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
    Koussoulas V; Vassiliou S; Spyridaki E; Demonakou M; Vaki I; Barbatzas C; Giamarellou H; Giamarellos-Bourboulis EJ
    World J Gastroenterol; 2007 Sep; 13(34):4610-4. PubMed ID: 17729416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
    Buzás G; Puscas I; Persa F; Reznicek A
    Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Topography of changes in the mucosa of the gastro-duodenal region in chronic gastritis and peptic ulcer].
    Pruglo IuV
    Arkh Patol; 1976; 38(11):50-9. PubMed ID: 1016081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol preclinical pharmacology.
    Bauer RF
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):118S-125S. PubMed ID: 3932042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the mucosal protective effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():117-29. PubMed ID: 3122272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point prevalence of peptic ulcer and gastric histology in healthy Indians with Helicobacter pylori infection.
    Misra V; Misra SP; Dwivedi M; Singh PA
    Am J Gastroenterol; 1997 Sep; 92(9):1487-91. PubMed ID: 9317069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis.
    Goldin E; Karmeli F; Rachmilewitz D
    Aliment Pharmacol Ther; 1991 Apr; 5(2):173-80. PubMed ID: 1909584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gastroduodenal ulcer pathology and prostaglandins].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
    [No Abstract]   [Full Text] [Related]  

  • 39. Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers.
    Shield MJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):178S-184S. PubMed ID: 3932052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial.
    Newman RD; Gitlin N; Lacayo EJ; Safdi AV; Ramsey EJ; Engel SL; Rubin A; Nissen CH; Swabb EA
    Am J Med; 1987 Jul; 83(1A):27-31. PubMed ID: 2887112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.